The novel mTOR inhibitor CCI-779 (temsirolimus) induces antiproliferative effects through inhibition of mTOR in Bel-7402 liver cancer cells

BACKGROUND: Liver cancer is one of the most frequent cancers in the world. Targeted therapy of cancer with specific inhibitors is developing and has shown promising antitumor efficacy. CCI-779 (temsirolimus), a specific inhibitor of mTOR (mammalian target of rapamycin), can block the mTOR signaling...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Li, Shuyu, Liang, Yan, Wu, Manlin, Wang, Xiaojing, Fu, Haixia, Chen, Yuhao, Wang, Zhigang
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2013
Pynciau:
Primary Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3632488/
https://ncbi.nlm.nih.gov/pubmed/23537100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-13-30
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg